Maria Sklodowska-Curie National Research Institute of Oncology
- Country
- 🇵🇱Poland
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.pib-nio.pl/
Clinical Trials
62
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (54 trials with phase data)• Click on a phase to view related trials
Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy
- Conditions
- Triple Negative Breast CancerUterine Cervical CancerUterine Corpus CancerMalignant MelanomaClear Cell Renal Cell Carcinoma
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-05-16
- Target Recruit Count
- 60
- Registration Number
- NCT06976021
Functional Abdominal Wall Reconstruction
- Conditions
- Prune Belly Syndrome
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-15
- Target Recruit Count
- 7
- Registration Number
- NCT06928974
- Locations
- 🇵🇱
Maria Sklodowska Curie Memorial National Cancer Center, Gliwice, Poland
Stereotactic Radiosurgery in the Treatment of Essential Tremor
- Conditions
- Essential Tremor
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-02-12
- Target Recruit Count
- 42
- Registration Number
- NCT06821906
- Locations
- 🇵🇱
Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2024-06-25
- Last Posted Date
- 2024-06-25
- Target Recruit Count
- 78
- Registration Number
- NCT06472583
- Locations
- 🇵🇱
Maria Sklodowska-Curie National Research Institute of Oncology , Gliwice Branch, Gliwice, Poland
Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2024-06-25
- Last Posted Date
- 2024-06-25
- Target Recruit Count
- 80
- Registration Number
- NCT06472570
- Locations
- 🇵🇱
1st Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch,, Gliwice, Gliwicw, Poland
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
News
Nemtabrutinib Shows Promise in Relapsed/Refractory Follicular Lymphoma
Nemtabrutinib demonstrates encouraging efficacy in patients with relapsed or refractory follicular lymphoma, according to findings from the BELLWAVE-003 phase 2 trial.